Sumary of Just 1% of black men with prostate cancer had the organ removed during pandemic:
- Black men with prostate cancer were much more likely to lose out on crucial treatment during the COVID-19 pandemic compared to white men, a new study suggests.
- In early months of the crisis, just one percent of black men with prostate cancer had the organ removed compared to 26 percent of white patients, researchers at Fox Chase Cancer Center in Philadelphia found.
- The two groups had similar COVID-19 risk factors and rates of biological signals indicating higher likelihood of severe cancer.
- Hospitals in urban centers have been more likely to get overwhelmed, for example.
- The new study, published Thursday in JAMA Oncology, demonstrates that the pandemic did, in fact, increase disparities in prostate cancer treatment.
- Prostate cancer affects one in seven black men in the U.S., the researchers wrote.
- Black patients are also more likely to receive a diagnosis of advanced prostate cancer – and more likely to die from the disease – compared to white patients.
- But when treatment is equitable, past studies have shown, it can improve these gaps in mortality, suggesting that care differences are to blame and not underlying biological differences.